TABLE 2.
Telomere length per 1 kb decrease |
|||
---|---|---|---|
Subjects n | HR (95% CI) | p-value | |
VUMC critically ill cohort | 937 | ||
90-day survival | |||
Unadjusted | 1.56 (1.32–1.83) | <0.0001 | |
Adjusted# | 1.30 (1.08–1.56) | 0.004 | |
1-year survival | |||
Unadjusted | 1.53 (1.33–1.78) | <0.0001 | |
Adjusted# | 1.27 (1.08–1.49) | 0.004 | |
VUMC sepsis subgroup | 368 | ||
90-day survival | |||
Unadjusted | 1.61 (1.27–2.06) | <0.0001 | |
Adjusted# | 1.54 (1.19–2.00) | 0.001 | |
1-year survival | |||
Unadjusted | 1.51 (1.22–1.86) | 0.0001 | |
Adjusted# | 1.41 (1.12–1.77) | 0.003 | |
UCSF sepsis cohort | 394 | ||
60-day survival | |||
Unadjusted | 1.53 (1.19–1.98) | 0.001 | |
Adjusted# | 1.57 (1.17–2.12) | 0.003 |
HR: hazard ratio.
: adjusted for age, sex, ethnicity, smoking status, and Acute Physiology and Chronic Health Evaluation (APACHE) II score.